Cleocin Vaginal Cream 2% is a branded prescription clindamycin phosphate cream labeled for intravaginal treatment of bacterial vaginosis. Its formulation and applicator package identify it as a vaginal medicine, not a skin acne cream or oral antibiotic. This page focuses on the branded standard cream rather than every form of vaginal clindamycin.
The standard Cleocin vaginal cream label describes an intravaginal course using applicators, which should not be confused with the distinct single-dose Clindesse brand. A listing that says only “clindamycin cream” may omit the most clinically important differences: route, product, strength and number of applications.
Patients looking to fill a U.S. prescription should verify the brand identity, tube/applicator presentation and the prescriber’s instructions with a licensed pharmacy. Current pharmacy supply cannot be inferred from a published FDA label or drug information page.
The Cleocin-branded 2% vaginal cream contains clindamycin phosphate in a formulation made for intravaginal delivery. It is a distinct marketed product family from Cleocin T skin preparations and from Cleocin HCl capsules. Sharing the name Cleocin does not make the products interchangeable.
The brand page exists to clarify the standard vaginal cream label and its dispensing identity. For a neutral overview of generic and branded vaginal creams, use the form-level cream guide rather than relying on this brand dossier.
| Question | Cleocin vaginal cream 2% | Different product to avoid confusing |
|---|---|---|
| Route | Intravaginal cream | Topical skin gel or oral capsules |
| Presentation | Standard cream tube with vaginal applicators | Clindesse single-dose prefilled cream |
| Active | Clindamycin phosphate | Other antibiotic or unrelated cream |
| Barrier warning | Mineral oil; avoid latex/rubber barriers within 72h after treatment | Clindesse has 5-day caution |
| Prescription | U.S. Rx required | OTC / no-Rx claim |
| Availability | Confirm actual item with pharmacy | Assuming label equals stock |
The 2% figure refers to clindamycin in a vaginal cream formulation. The standard Cleocin product is supplied for an intravaginal regimen, with applicators used to deliver the prescribed amount. The amount of medication in an application is not interchangeable with the milligrams printed on a vaginal ovule.
Because product-specific regimens vary, the pharmacy label and clinician instruction are controlling. This page is not a personalized regimen recommendation and should not be used to change course length or applicator technique.
Cleocin Vaginal Cream and Clindesse both involve vaginal clindamycin cream, but Clindesse has its own single-dose, prefilled applicator product design and labeling. A pharmacy search result may present both under an undifferentiated “vaginal clindamycin 2%” query.
See Clindesse vs Cleocin vaginal cream for the dedicated comparison; the products should not be switched solely because they share an ingredient concentration.
Clindamycin vaginal cream is intended for intravaginal use in the specific setting identified by its label. It is not a topical acne cream and is not designed for swallowing. The vehicle, applicator and counseling information differ from those of oral capsules and skin gels.
If the condition or prescription is unclear, the bacterial-vaginosis clinical guide explains the diagnosis and treatment framework without turning the brand page into condition-specific prescribing advice.
Ask whether the listing specifies Cleocin vaginal cream 2%, the correct tube quantity, the included vaginal applicators and the exact patient directions. A brand photo may not represent the currently dispensed package. Confirm that the pharmacist can show the product identity on the prescription record.
The vaginal clindamycin purchase guide addresses fulfillment steps across gel, ovule and cream routes, while this page stays focused on Cleocin vaginal cream.
The Cleocin Vaginal Cream label cautions that its mineral-oil base may weaken latex or rubber condoms and diaphragms. It advises against using those products within 72 hours after treatment; the patient should also follow the label’s instructions during treatment.
This is not a universal rule for every vaginal clindamycin medicine: Clindesse has a five-day post-treatment warning, and Xaciato gel has a different polyurethane-condom warning. Ask a clinician or pharmacist about suitable protection for the specific medicine.
The Cleocin cream patient information advises against vaginal intercourse or using other intravaginal products such as tampons or douches during treatment. These instructions come from the particular product label and should not be generalized to all antibiotics.
If a patient uses vaginal devices, contraception or additional intravaginal medicines, those details should be discussed during clinical assessment. Avoid assuming that any product sold under the clindamycin name has identical counseling requirements.
Cleocin Vaginal Cream 2% is contraindicated in patients with hypersensitivity to clindamycin, lincomycin or any component of the cream, and in those with a history of regional enteritis, ulcerative colitis or antibiotic-associated colitis. This is more specific than a general recommendation to discuss digestive symptoms with a clinician. Vaginal administration does not entirely eliminate systemic absorption or antibiotic-associated colitis risk.
Patients should seek prompt medical advice for significant or persistent diarrhea, bloody stools, severe abdominal pain or allergic symptoms during or after treatment. Vaginal irritation and yeast-related symptoms also merit attention if severe, persistent or unexpected. The C. difficile guide explains why new significant diarrhea after vaginal clindamycin requires assessment instead of simply assuming it is unrelated.
A generic clindamycin phosphate 2% vaginal cream may appear alongside the Cleocin name in pharmacy systems. Availability, therapeutic equivalence, packaging and insurance coverage require a product-specific check. Some brand names also persist in historical reference material after packaging changes.
A substitution should be approved by the pharmacist according to applicable law and the prescriber’s order. The generic product guide covers wider route and salt differences.
U.S. Cleocin vaginal cream is prescription-only. A legitimate pharmacy verifies the clinician order, formulation and patient directions and provides a pharmacist for questions. Marketing statements about bypassing a prescription or immediate availability are not a trustworthy substitute for verification.
See online pharmacy verification if ordering remotely. A remote clinician visit may assess symptoms but cannot guarantee a particular antibiotic will be prescribed.
The cost depends on brand versus generic selection, package quantity, insurance benefits and pharmacy billing. Cream, gel and ovule products should not be treated as a single interchangeable price category.
Ask for the amount charged for the exact Cleocin cream prescription after coverage and any applicable pharmacy terms are checked. The vaginal clindamycin cost guide describes evergreen cost factors without posting unverified prices.
Check that the dispensed carton, concentration, applicators, route and label match the order. Ask how to follow the package directions and when to seek care for worsening symptoms or adverse effects. Report any mismatch between a cream tube and a single-dose prefilled product.
If a pharmacist proposes an alternate brand or vehicle, discuss it with the prescriber rather than inferring equivalent use from the shared 2% clindamycin concentration.
It is a branded prescription clindamycin phosphate cream intended for intravaginal treatment of bacterial vaginosis.
No. Cleocin T is for topical skin use, whereas the vaginal cream is a different formulation and route.
The standard Cleocin vaginal cream is not the single-dose Clindesse product; follow the specific dispensed label.
Its mineral-oil base can weaken latex or rubber products. The label advises against their use within 72 hours following treatment.
Yes. U.S. clindamycin vaginal cream is prescription-only.
No. Xaciato is a distinct clindamycin vaginal gel with different packaging and safety counseling.
No. Confirm current supply and the exact product with a licensed pharmacy.
Only when the pharmacist confirms an appropriate product under the prescription and applicable substitution rules.
Yes. The label lists regional enteritis, ulcerative colitis and a history of antibiotic-associated colitis as contraindications, along with hypersensitivity to clindamycin, lincomycin or components of the cream.